Unstable angina and non-Q wave myocardial infarction: Does the clinical diagnosis have therapeutic implications?

Journal of the American College of Cardiology

Volumn 33, Issue 1, 1999, Pages 107-118

  Zaacks, Stephen M ^a   Liebson, Philip R ^a   Calvin, James E ^a   Parrillo, Joseph E ^a   Klein, Lloyd W ^a,b  

^a RUSH MEDICAL COLLEGE   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CATECHOLAMINE; CREATINE KINASE; CREATINE KINASE MB; DALTEPARIN; DILTIAZEM; ENOXAPARIN; FIBRINOGEN; FIBRINOGEN RECEPTOR ANTAGONIST; FIBRINOLYTIC AGENT; FIBRONECTIN; HEART ENZYME; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; METOPROLOL; MYOGLOBIN; NIFEDIPINE; NITRATE; PROPRANOLOL; SEROTONIN; THALLIUM 201; THROMBOXANE; TROPONIN; UNINDEXED DRUG; VASOACTIVE AGENT; VERAPAMIL; VON WILLEBRAND FACTOR;

ALGORITHM; ANAMNESIS; ANGIOCARDIOGRAPHY; ANGIOSCOPY; ATHERECTOMY; ATHEROSCLEROTIC PLAQUE; CLINICAL FEATURE; CLINICAL TRIAL; CORONARY STENT; DRUG EFFICACY; ELECTROCARDIOGRAPHY; EXERCISE TEST; FIBRINOLYTIC THERAPY; HEART CATHETERIZATION; HEART INFARCTION; HIGH RISK PATIENT; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; META ANALYSIS; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THROMBOCYTE AGGREGATION; THROMBUS; UNSTABLE ANGINA PECTORIS;

EID: 0032945553     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(98)00553-1     Document Type: Article

References (110)

1. Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes (Part I). N Engl J Med 1992;326:242-50.
2. Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes (Part II). N Engl J Med 1992;326:310-8.
3. Klein LW, Helfant RH. The Q-wave and non-Q wave myocardial infarction: differences and similarities. Progress in Cardiovascular Diseases 1986;29:205-20.
4. Liebson PR, Klein LW. The non-Q wave myocardial infarction revisited: 10 years later. Progress in Cardiovascular Diseases 1997;39;399-444.
5. Yusuf S, Wittes J, Friedman L. Overview of results of randomized clinical trials in heart disease II. Unstable angina, heart failure, primary prevention with aspirin, and risk factor modification. JAMA 1988;260:2259-63.
6. Yusuf S, Wittes J, Friedman L. Overview of results of randomized clinical trials in heart disease I: treatments following myocardial infarction. JAMA 1988;260:2088-93.
7. Boden WE, Krone RT, Kleiger RE for the Multicenter Diltiazem Post-Infarction Trial Research Group: electrocardiographic subset analysis of diltiazem administration on long-term outcome after acute myocardial infarction. Am J Cardiol 1991;67:335-42.
8. Yusuf S, Furberg CD. Effects of calcium channel blockers on survival after myocardial infarction. Cardiovasc Drugs Ther 1987;1:343-4.
9. Davies MJ, Thomas AC. Plaque fissuring-the cause of acute myocardial infarction, sudden ischemic death, and crescendo angina. Br Heart J 1985;53:363-73.
10. Moreno PR, Falk E, Palacios IF, Newell JB, Fuster V, Fallon JT. Macrophage infiltration in acute coronary syndromes: implications for plaque rupture. Circulation 1994;90:775-8.
11. Bresnahan DR, Davis JL, Holmes DR. Smith HC. Angiographic occurrence and clinical correlates of intraluminal coronary artery thrombus: role of unstable angina. J Am Coll Cardiol 1985;6:285-9.
12. Fuster V, Badimon L, Cohen M, Ambrose JA, Badimon JJ, Chesebro J. Insights into the pathogenesis of acute ischemic syndromes. Circulation 1988;77:1213-20.
13. Theroux P. Angiographic and clinical progression in unstable angina. From clinical observations to clinical trials. Circulation 1995;91:2295-8.
14. Hamm CW, Lorenz RL, Bleifeld W, Kupper W, Wober W, Weber PC. Biochemical evidence of platelet activation in patients with persistent unstable angina. J Am Coll Cardiol 1987;10:998-1004.
15. Mehta JL. Platelet activation in unstable angina: role of thromboxane A2 and other mediators of vasoconstriction. J Am Coll Cardiol 1990;15:727-9.
16. Gorlin R, Fuster V, Ambrose JA. Anatomic-physiologic links between acute coronary syndromes. Circulation 1986;74:6-9.
17. Depre C, Wijns W, Robert AM, Renkin JP, Havaux X. Pathology of unstable plaque: correlation with the clinical severity of acute coronary syndromes. J Am Coll Cardiol 1997;30:694-702.
18. Ambrose JA, Winters SL, Arora RR, et al. Coronary angiographic morphology in myocardial infarction: a link between the pathogenesis of unstable angina and myocardial infarction. J Am Coll Cardiol 1985;6: 1233-8.
19. Ambrose JA, Winter SL, Arora RR, et al. Angiographic evolution of coronary artery morphology in unstable angina. J Am Coll Cardiol 1986;7: 472-8.
20. Ambrose JA, Israel D. Angiographic correlations of complex lesions in acute coronary syndromes. In: Ambrose JA, editor. Complex Coronary Lesions in Acute Coronary Syndromes. New York: Futura Publishing Company, 1996:49-72.
21. Klein LW. Unstable angina and non-Q wave myocardial infarction: pathogenetic mechanisms and morphology of the unstable plaque. In: Klein LW, editor. Coronary Stenosis Morphology: Analysis and Implication. Kluwer Academic Publishers, 1997:177-210.
22. Chen L, Chester MR, Redwood S, Huang J, Leatham E, Kaski JC. Angiographic stenosis progression and coronary events in patients with "stabilized" unstable angina. Circulation 1995;91:2319-24.
23. Ambrose JA, Winters SL, Arora RR, Riccio A, Gorlin R, Fuster V. Angiographic evolution of coronary morphology in unstable angina. J Am Coll Cardiol 1986;7:472-8.
24. Ahmed WH, Bittl JA, Braunwald E. Relation between clinical presentation and angiographic findings in unstable angina pectoris, and comparison with that in stable angina. Am J Cardiol 1993;72:544-50.
25. Bugiardini R, Borghi A, Pozzati A, et al. Is chest pain a reliable predictor of subsequent coronary events in unstable angina [abstract]? Eur Heart J 1992;13:205.
26. Dangas G, Mehran R, Wallenstein S, et al. Correlation of angiographic morphology and clinical presentation in unstable angina. J Am Coll Cardiol 1997;29:519-25.
27. Ambrose JA. Plaque disruption and the acute coronary syndromes of unstable angina and myocardial infarction: if the substrate is similar, why is the clinical presentation different? J Am Coll Cardiol 1992;19:1653-8.
28. Mizuno K, Satamura K, Miyamoto A, Arakawa K, Shibuya T, Arai T, Kunita A, Nakamura H, Ambrose JA. Angioscopic evaluation of coronary artery thrombi in acute coronary syndromes. N Eng J Med 1992;326:287-91.
29. Haft JI, Mariano DL, Goldstein J. Comparison of the histopathology of culprit lesions in chronic stable angina, unstable angina, and myocardial infarction. Clin Cardiol 1997;20:651-5.
30. DeWood MA, Stiffer WF, Simpson CS, et al. Coronary angiographic findings soon after non-Q wave myocardial infarction. N Engl J Med 1986;315:417-23.
31. Dacanay S, Kennedy HL, Uretz E, Parrillo JE, Klein LW. Morphological and quantitative angiographic analyses of progression of coronary stenoses: a comparison of Q wave and non-Q wave myocardial infarction. Circulation 1994;90:1739-46.
32. Davies SW, Marchant B, Lyons JB, et al. Coronary lesion morphology in acute myocardial infarction: demonstration of early remodelling after streptokinase treatment. J Am Coll Cardiol 1990;16:1079-86.
33. Veen G, Meijer A, Werter CJPJ, et al. Dynamic changes of culprit lesion morphology and severity after successful thrombolysis for acute myocardial infarction: an angiographic follow-up study. J Am Coll Cardiol 1994;23: 147A.
34. Cannon CP, Thompson B, McCabe CH, et al. for the TIMI III investigators. Predictors of non-Q wave acute myocardial infarction in patients with acute ischemic syndromes: an analysis from the Thrombolysis in Myocardial Ischemia (TIMI) III Trials. Am J Cardiol 1995;75:977-81.
35. Langer A, Freeman MR, Armstrong PW. ST segment shift in unstable angina: pathophysiology and association with coronary anatomy and hospital outcome. J Am Coll Cardiol 1989;13:1495-502.
36. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet 1994;343:311-22.
37. Schechtman KB, Capone RJ, Kleiger RE, et al. Risk stratification of patients with non-Q wave myocardial infarction: the critical role of ST segment depression. Circulation 1989;80:1148-58.
38. Nyman I, Areskog M, Areskog N-H, et al. Very early risk stratification by electrocardiogram at rest in men suspected with unstable coronary heart disease. J Int Med 1993;234:293-301.
39. Willich SN, Stone PH, Muller JE, et al. High-risk subgroups of patients with non-Q wave myocardial infarction based on direction and severity of ST segment deviation. Am Heart J 1987;114:1110-9.
40. Schectman KB, Capone RJ, Kleiger RE, Gibson RS, Schwartz DJ, Roberts R, Young PM, Boden WE, and the Diltiazem Reinfarction Study Research Group. Circulation 1989;80:1148-58.
41. Califf RM, Tomabechi Y, Lee KL, et al. Outcome in one-vessel coronary artery disease. Circulation 1983;67:283-90.
42. Taniguchi H, Iwasaka T, Sugiura T, et al. Acute pulmonary edema in patients with unstable angina: clinical profile and natural history. Coron Artery Dis 1992;3:529-32.
43. Emond M, Mockj MB, Davis KB, et al. Long-term survival of medically treated patients in the coronary artery surgery study (CASS) registry. Circulation 1994;90:2645-57.
44. Braunwald E. Unstable angina: a classification. Circulation 1989;80:410-4.
45. Calvin JE, Klein LW, Vandenberg BJ, Meyer P, Condon JV, Snell RJ, Ramirez-Morgan LM, Parrillo JE. Risk stratification in unstable angina: prospective validation of the Braunwald classification. JAMA 1995;273: 136-41.
46. Van Miltenberg-Van Zijl AJM, Simoons ML, Veerhoek RJ, Bossuyt PMM. Incidence and follow up of Braunwald subgroups in unstable angina pectoris. J Am Coll Cardiol 1995;25:1286-92.
47. Haim M, Hod H, Reisin L, et al. Comparison of short and long term prognosis in patients with anterior wall versus inferior or lateral wall non-Q wave myocardial infarction. Secondary Prevention Reinfarction Israeli Nifedipine Trial (SPRINT) Study Group. Am J Cardiol 1997;79:717-21.
48. Schectman KB, Capone RJ, Kleiger RE, et al. and the Diltiazem Reinfarction Study Group: differential risk patterns associated with 3 month as compared with 3 to 12 month mortality and reinfarction after non-Q wave myocardial infarction. J Am Coll Cardiol 1990;15:940-7.
49. Sharkey SW, Apple FS, Elsperger KJ, et al. Early peak of creatinine kinase-MB in acute myocardial infarction with a nondiagnostic electrocardiogram. Am Heart J 1988;116:1207-11.
50. Armstrong PW, Chiong MA, Parker JO. The spectrum of unstable angina: prognostic role of serum creatinine kinase determination. Am J Cardiol 1982;49:1849-52.
51. Adams JE, Abendschein DR, Jaffe AS. Biochemical markers of myocardial injury: is MB creatinine kinase the choice for the 1990's? Circulation 1993;88:750-63.
52. Adams JE, Bodor GS, Davila-Roman VG, et al. Cardiac Troponin I: a marker with high specificity for cardiac injury. Circulation 1993;88:101-6.
53. Hamm CW, Ravkilde J, Gerhardt W. The prognostic value of serum troponin T in unstable angina. N Engl J Med 1992;327:146-50.
54. Stubbs P, Collinson P, Moseley D, Greenwood T, Noble M. Prognostic significance of admission troponin T concentrations in patients with myocardial infarction. Circulation 1996;94:1291-7.
55. Ohman EM, Armstrong PW, Christenson RH, et al. Cardiac troponin T levels for risk stratification in acute myocardial ischemia. N Engl J Med 1996;335:1333-41.
56. Antman EM, Tanasijevic MJ, Thompson B, et al. Cardiac-specific troponin-I levels to predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med 1996;335:1342-9.
57. Lindahl B, Venge P, Wallentin L for the FRISC study group. Relation between troponin T and the risk of subsequent cardiac events in unstable coronary artery disease. Circulation 1996;93:1651-7.
58. Galvani M, Ottani F, Ferrini D, et al. Prognostic significance of elevated values of cardiac troponin I in patients with unstable angina. Circulation 1997;95:2053-9.
59. Pitt B. Risk stratification in patients with unstable angina: "deja vu" all over again? Circulation 1996;93:1618-20.
60. Hamm CW, Goldmann BU, Heeschen C, Kreymann G, Berger J, Meinertz T. Emergency room triage of patients with acute chest pain by means of rapid testing for cardiac troponin T or troponin I. N Engl J Med 1997;337:1648-53.
61. Polanczyk CA, Lee TH, Cook EF, et al. Cardiac troponin I as a predictor of major cardiac events in emergency department patients with acute chest pain. J Am Coll Cardiol 1998;32:8-14.
62. Haft JI, Saadeh SA. Cardiac troponins in acute coronary syndromes. N Engl J Med 1997;336:1257.
63. de Feyter PJ, Serruys PW, Soward A, van den Brand M, Bos E, Hugenholtz PG. Coronary angioplasty for early postinfarction unstable angina. Circulation 1986;74:1365-70.
64. Lotan CS, Jonas M, Rozenman Y, et al. Comparison of early invasive and conservative treatments in patients with anterior wall non-Q wave acute myocardial infarction. Am J Cardiol 1995;76:330-6.
65. Anderson HV, Cannon CP, Stone PH, et al. One-year results of the Thrombolysis in Myocardial Infarction (TIMI) IIIB Clinical Trial. J Am Coll Cardiol 1995;26:1643-50.
66. Boden WE, O'Rourke RA, Crawford MH, et al. Outcomes in patients with acute non-Q wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy: Veterans Affairs Non-Q Wave Infarction Strategies in Hospital (VANQWISH). N Engl J Med 1998;338:1786-92.
67. Williams DO, Braunwald E, Thompson B, Sharif BL, Buller CE, Knatterud GL. Results of percutaneous transluminal coronary angioplasty in unstable angina and non-Q wave myocardial infarction: observations from the TIMI IIIB trial. Circulation 1996;94:2749-55.
68. Theroux P, Ouimet H, McCans J, et al. Aspirin, heparin, or both to treat acute unstable angina. N Engl J Med 1988;319:1105-11.
69. Theroux P, Waters D, Lam J, Juneau M, McCans J. Reactivation of unstable angina after the discontinuation of heparin. N Engl J Med 1992;327:141-5.
70. Lewis DH, Davis JW, Archibald DG, et al. Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina. N Engl J Med 1983;309:396-403.
71. The RISC group. Risk of myocardial infarction and death during treatment with low dose aspirin and intravenous heparin in men with unstable coronary artery disease. The Lancet 1990;336:827-30.
72. Cohen M, Xiong J, Parry G, et al. Prospective comparison of unstable angina versus non-Q wave myocardial infarction during antithrombotic therapy. J Am Coll Cardiol 1993;22:1338-44.
73. Klein LW, Wahid F, VandenBerg BJ, Parrillo JE, Calvin JE. Comparison of heparin therapy for < or = 48 hours to > 48 hours in unstable angina pectoris. Am J Cardiol 1997;79:259-63.
74. Gibson RS, Boden WE, Theroux P, et al. Diltiazem and reinfarction in patients with non-Q wave myocardial infarction. N Engl J Med 1986;315: 423-9.
75. Gibson RS, Young PM, Boden WE, et al. Prognostic significance and beneficial effect of diltiazem on the incidence of early recurrent ischemia after non-Q wave myocardial I infarction: results from the Multicenter Diltiazem Reinfarction Study. Am J Cardiol 1987;60:203-9.
76. The Danish Study Group: verapamil in acute myocardial infarction. Eur Heart J 1984;5:516-28.
77. Muller JE, Morrison J, Stone PH, et al. Nifedipine therapy for patients with threatened and acute myocardial infarction. Circulation 1984;69:740-7.
78. Sirnes PA, Overskeid K, Pedersen TR, et al. Evolution of infarct size during the early use of nifedipine in patients with acute myocardial infarction: The Norwegian Nifedipine Multicenter Trial. Circulation 1984;70:638-44.
79. Gheorghiade M, Schultz L, Tilley B, et al. Effects of propranolol in non-Q wave acute myocardial infarction in the Beta Blocker Heart Attack Trial. Am J Cardiol 1990;66:129-33.
80. The MIAMI Trial Research Group: Mortality. Am J Cardiol 1985;56:15G-22G.
81. Waters D, Azar RR. Low-molecular-weight heparins for unstable angina, a better mousetrap? Circulation 1997;96:3-5.
82. Swahn E, Wallentin L, for the FRISC Study Group. Low-molecular-weight heparin (Fragmin) during instability in coronary artery disease (FRISC). Am J Cardiol 1997;80(5A):25E-9E.
83. Klein W, Buchwald A, Hillis WS, et al. on behalf of the FRIC investigators. Fragmin in unstable angina pectoris or in non-Q wave acute myocardial infarction (FRIC). Am J Cardiol 1997;80(5A):30E-4E.
84. Cohen M, Demers C, Gurfinkel EP. A comparison of low molecular weight heparin with unfractionated heparin for unstable coronary artery disease. N Engl J Med 1997;337:447-52.
85. The EPIC Investigators. Use of a monoclonal antibody directed against the platelet glycoprotein Iib/IIIa receptor in high-risk coronary angioplasty. N Engl J Med 1994;330:956-61.
86. The EPILOG Investigators. Platelet glycoprotein IIB/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization. N Engl J Med 1997;336:1689-96.
87. The CAPTURE Investigators. Randomized placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina. Lancet 1997;349:1429-35.
88. The PRISM-PLUS Study Investigators. Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q wave myocardial infarction. N Engl J Med 1998;338:1488-97.
89. The PRISM Study Investigators. A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina. N Engl J Med 1998;338:1498-1505.
90. The RESTORE Investigators. Effects of Platelet Glycoprotein IIb/IIIa blockade with Tirofiban on adverse cardiac events in patients with unstable angina or acute myocardial infarction undergoing coronary angioplasty. Circulation 1997;96:1445-53.
91. Harrington RA for the PURSUIT investigators. A symposium: acute ischemic coronary syndromes - The PURSUIT Trial. Am J Cardiol 1997; 80:36B-8B.
92. Theroux P, Kanz S, Roy L, and the Canadian Lamifiban Study Investigators. Platelet membrane receptor glycoproteins IIb/IIIa antagonism in unstable angina. Circulation 1996;94:899-905.
93. Harrington RA, Moliterno DJ, Van de Werf F, et al. for the PARAGON Investigators. Delaying and preventing ischemic events in patients with acute coronary syndromes using the platelet glycoprotein Iib/IIIa inhibitor lamifiban. [abstract]. J Am Coll Cardiol 1997;29:409A.
94. Kereiakes DJ, Kleiman N, Ferguson JJ, et al. Sustained platelet glycoprotein IIb/IIIa blockade with oral xemilofiban in 170 patients after coronary stent deployment. Circulation 1997;96:1117-21.
95. Ambrose JA, Hjemdahl-Monsen C, Borrico S, et al. Quantitative and qualitative effects of intracoronary streptokinase in unstable angina and non-Q wave infarction. J Am Coll Cardiol 1987;9:1156-65.
96. Williams DO, Topol EJ, Califf RM, et al. Intravenous recombinant tissue-type plasminogen activator in patients with unstable angina pectoris. Circulation 1990;82:376-83.
97. Bar FW, Raynaud P, Renkin JP, Vermeer F, de Zwaan C, Wellen HJ. Coronary angiographic findings do not predict clinical outcome in patients with unstable angina. J Am Coll Cardiol 1994;24:1453-9.
98. The TIMI IIIB investigators. Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q wave myocardial infarction. Results of the TIMI IIIB Trial. Circulation 1994;89:1545-56.
99. Mehran R, Ambrose JA, Bongu RM, et al. Angioplasty of complex lesions in ischemic rest angina: results of the Thrombolysis and Angioplasty in Unstable Angina (TAUSA) trial. J Am Coll Cardiol 1995;26:961-6.
100. Waters D, Lam JYT. Is thrombolytic therapy striking out in unstable angina? Circulation 1992;86:1642-4.
101. Marzocchi A, Piovaccari G, Marrozzini C, et al. Results of coronary stenting for unstable versus stable angina pectoris. Am J Cardiol 1997;79: 1314-8.
102. Bertaglia E, Ramondo A, Cacciavillani L, et al. Percutaneous transluminal coronary angioplasty in refractory unstable angina pectoris: are new devices useful? Int J Cardiol 1996;57:1-7.
103. Williams DO, Braunwald E, Thompson B, Sharaf BL, Buller CE, Knatterud GL. Results of percutaneous transluminal coronary angioplasty in unstable angina and non-Q wave myocardial infarction: observations from the TIMI IIIB Trial. Circulation 1996;94:2749-55.
104. Zannad F, Amor M, Karcher G, et al. Effect of diltiazem on myocardial infarct size estimated by enzyme release, serial thallium-201 single-photon emission computed tomography and radionuclide angiography. Am J Cardiol 1988;61:1172-7.
105. Zareba W, Moss AJ, Raubertas RF. Risk of subsequent cardiac events in stable convalescing patients after first non-Q wave and Q wave myocardial infarction: the limited role of non-invasive testing. Coron Artery Dis 1994;5:1009-18.
106. Stratmann HG, Younis LT, Wittry MD, Amato M, Miller DD. Exercise technetium-99m myocardial tomography for the risk stratification of men with medically treated unstable angina pectoris. Am J Cardiol 1995;76:236-40.
107. Stratmann HG, Tamesis BR, Younis LT, Wittry MD, Amato M, Miller DD. Prognostic value of predischarge dypiridamole technetium 99m sestamibi myocardial tomography in medically treated patients with unstable angina. Am Heart J 1995;130:734-40.
108. Blomstrand P, Karlsson JE, Engrall J, Nylander E, Bjorkholm A, Wallentin L, Wranne B. Exercise echocardiography and thallium-201 single-photon emission computed tomography in male patients after an episode of unstable coronary artery disease. Am J Card Imaging 1994;8:283-9.
109. Eriksson SV, Erhardt L, Lindvall K, Melcher A, Rehnqvist N. Long-term prognostic importance of exercise echocardiography after an episode of unstable angina. Cardiology 1995;86:426-31.
110. Braunwald E, Jones RH, Mark DB, et al. Diagnosing and managing unstable angina. Circulation 1994;90:613-22.